Skip to main content
    M

    Medtronic PLC (MDT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $94.78
    -0.63 (-0.66%)

    Market Cap: $122.04B

    Last updated: Oct 27, 2026 at 10:41 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    95%(38/40)
    Avg Surprise
    +9.11%
    Streak
    17 Q

    Upcoming Estimates

    Period ending Oct 31, 2026
    EPS Consensus$1.33
    Range$1.32 - $1.34
    25 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$1.35-1.1%
    60d ago$1.35-1.1%
    30d ago$1.33+0.1%
    7d ago$1.33-0.0%
    Current$1.33
    Revenue Consensus
    $9.5B
    Range$9.4B - $9.5B
    24 analysts
    Period ending Jan 31, 2027
    EPS Consensus$1.42
    Range$1.40 - $1.48
    24 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$1.43-0.5%
    60d ago$1.43-0.5%
    30d ago$1.42+0.0%
    7d ago$1.42-0.0%
    Current$1.42
    Revenue Consensus
    $9.5B
    Range$9.5B - $9.7B
    23 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Apr 27EST
    		-$1.83---
    Jan 27EST
    		-$1.42---
    Oct 26EST
    		-$1.33---
    Jul 26
    Reported Sep 1
    		$1.45$1.39+4.32%Beat+15.1%
    Apr 26
    Reported Jun 3
    		$1.55$1.54+0.65%Beat-4.3%
    Jan 26
    Reported Feb 17
    		$1.36$1.34+1.49%Beat-2.2%
    Oct 25
    Reported Nov 18
    		$1.36$1.31+3.82%Beat+7.9%
    Jul 25
    Reported Aug 19
    		$1.26$1.23+2.44%Beat+2.4%
    Apr 25
    Reported May 21
    		$1.62$1.58+2.53%Beat+11.0%
    Jan 25
    Reported Feb 18
    		$1.39$1.36+2.21%Beat+6.9%
    Oct 24
    Reported Nov 19
    		$1.26$1.25+0.80%Beat+0.8%
    Jul 24
    Reported Aug 20
    		$1.23$1.20+2.50%Beat+2.5%
    Apr 24
    Reported May 23
    		$1.46$1.45+0.69%Beat-7.0%
    Jan 24
    Reported Feb 20
    		$1.30$1.26+3.17%Beat+0.0%
    Oct 23
    Reported Nov 21
    		$1.25$1.18+5.93%Beat-3.8%
    Jul 23
    Reported Aug 22
    		$1.20$1.11+8.11%Beat+6.2%
    Apr 23
    Reported May 25
    		$1.57$1.55+1.29%Beat+3.3%
    Jan 23
    Reported Feb 21
    		$1.30$1.27+2.36%Beat-5.1%
    Oct 22
    Reported Nov 22
    		$1.30$1.28+1.56%Beat-1.5%
    Jul 22
    Reported Aug 23
    		$1.13$1.12+0.89%Beat-19.9%
    Apr 22
    Reported May 26
    		$1.52$1.56-2.56%Miss+1.3%
    Jan 22
    Reported Feb 22
    		$1.37$1.37+0.00%Beat+6.2%
    Oct 21
    Reported Nov 23
    		$1.32$1.29+2.33%Beat+29.4%
    Jul 21
    Reported Aug 24
    		$1.41$1.32+6.82%Beat+127.4%
    Apr 21
    Reported May 27
    		$1.50$1.42+5.63%Beat+158.6%
    Jan 21
    Reported Feb 23
    		$1.29$1.15+12.17%Beat-10.4%
    Oct 20
    Reported Nov 24
    		$1.02$0.80+27.50%Beat-22.1%
    Jul 20
    Reported Aug 25
    		$0.62$0.18+244.44%Beat-50.8%
    Apr 20
    Reported May 21
    		$0.58$0.75-22.67%Miss-62.3%
    Jan 20
    Reported Feb 18
    		$1.44$1.38+4.35%Beat+11.6%
    Oct 19
    Reported Nov 19
    		$1.31$1.28+2.34%Beat+7.4%
    Jul 19
    Reported Aug 20
    		$1.26$1.19+5.88%Beat+7.7%
    Apr 19
    Reported May 23
    		$1.54$1.47+4.76%Beat+8.5%
    Jan 19
    Reported Feb 19
    		$1.29$1.24+4.03%Beat+10.3%
    Oct 18
    Reported Nov 20
    		$1.22$1.15+6.09%Beat+14.0%
    Jul 18
    Reported Aug 21
    		$1.17$1.11+5.41%Beat+4.5%
    Apr 18
    Reported May 24
    		$1.42$1.39+2.16%Beat+6.8%
    Jan 18
    Reported Feb 20
    		$1.17$1.17+0.00%Beat+4.5%
    Oct 17
    Reported Nov 21
    		$1.07$1.03+3.88%Beat-4.5%
    Jul 17
    Reported Aug 22
    		$1.12$1.08+3.70%Beat-
    Apr 17
    Reported May 25
    		$1.33$1.31+1.53%Beat-
    Jan 17
    Reported Feb 21
    		$1.12$1.11+0.90%Beat-
    Oct 16
    Reported Nov 22
    		$1.12$1.11+0.90%Beat-

    Dividends

    Dividend Metrics

    Forward Yield3.04%
    Forward Annual Dividend$2.88
    Payout Ratio45.55%
    FrequencyQuarterly
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR+1.96%
    5Y CAGR+4.42%
    MDT dividend history and ex-dividend datesRun MDT in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio16.57EV/EBITDA14.39x
    Price/FCF19.78xFCF Yield5.06%
    Profitability
    Profit Margin13.90%Operating Margin19.30%
    ROE10.60%ROIC7.46%
    Financial Health
    Debt/Equity0.56xInterest Coverage10.11x
    Current Ratio2.07xQuick Ratio1.54x
    Trading Statistics
    Beta0.57Avg Volume32.97M
    52-Week High$102.9252-Week Low$72.06

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$94.47
    SMA 20$90.98
    SMA 50$91.02
    SMA 200$87.28
    EMA 10$93.88
    EMA 20$92.44
    EMA 50$90.37
    EMA 200$87.87

    MACD

    Line: 1.59Signal: 1.11Hist: 0.48

    ADX

    ADX: 21.7+DI: 21.9-DI: 17.2

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down32.0
    PSAR$93.53

    Bollinger Bands

    Upper Band$98.73
    Lower Band$83.22
    %B Position1705%(Upper)
    Band Width0.74

    RSI (14-Day)

    Neutral
    58.2

    Momentum Oscillators

    Stoch %K89.4
    Stoch %D86.1
    Williams %R-18.4
    ROC (10d)3.1%
    Momentum2.85
    CCI (20d)74.1
    MFI (14d)72.5

    Volatility Measures

    ATR (14d)$2.36(2.5%)
    StdDev (20d)3.88
    Hist Vol30.4%(Moderate)

    Volume Flow

    VWAP$94.86
    OBV125.3M
    AD Line-4.1B
    CMF (20d)0.041

    Volume Metrics

    Avg Vol (20d)33.5M
    Vol Ratio0.2x(Low)
    VWMA (20d)$89.83

    Pivot Points

    R3$97.92
    R2$97.40
    R1$96.41
    Pivot Point$95.89
    S1$94.90
    S2$94.38
    S3$93.39

    Advanced Oscillators

    TSI17.59
    Ultimate Osc47.7
    KST41.59

    Financial Data

    QuarterJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Total Revenue$9.76B$9.81B$9.02B$8.96B$8.58B$8.93B$8.29B$8.40B$7.92B$8.59B$8.09B$7.98B
    Cost of Revenue$3.42B$3.40B$3.26B$3.06B$3.00B$3.15B$2.78B$2.95B$2.76B$3.04B$2.78B$2.76B
    Gross Profit$6.34B$6.41B$5.76B$5.90B$5.58B$5.78B$5.51B$5.46B$5.15B$5.54B$5.31B$5.22B
    Operating Expenses$4.58B$4.54B$4.29B$4.21B$4.13B$4.34B$3.87B$3.86B$3.87B$4.49B$3.82B$3.88B
    R&D$771.00M$671.00M$722.00M$754.00M$726.00M$684.00M$675.00M$697.00M$676.00M$674.00M$695.00M$698.00M
    SG&A$3.20B$3.06B$2.96B$2.96B$2.81B$2.72B$2.72B$2.76B$2.65B$2.76B$2.67B$2.69B
    Operating Income$1.76B$1.87B$1.46B$1.69B$1.45B$1.44B$1.65B$1.59B$1.28B$1.05B$1.48B$1.34B
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$186.00M$177.00M$181.00M$181.00M$176.00M$174.00M$179.00M$209.00M$167.00M$203.00M$188.00M$180.00M
    Income Before Tax$1.77B$1.83B$1.40B$1.60B$1.30B$1.26B$1.54B$1.56B$1.27B$856.00M$1.47B$1.31B
    Income Tax Expense$289.00M$575.00M$254.00M$215.00M$255.00M$198.00M$237.00M$281.00M$220.00M$196.00M$135.00M$402.00M
    Net Income$1.48B$1.26B$1.15B$1.38B$1.05B$1.06B$1.30B$1.28B$1.05B$660.00M$1.34B$911.00M
    EBITDA$2.68B$2.73B$2.33B$2.52B$2.23B$2.28B$2.40B$2.44B$2.10B$1.71B$2.31B$2.17B
    EBIT$1.95B$2.01B$1.58B$1.78B$1.48B$1.44B$1.72B$1.77B$1.44B$1.06B$1.66B$1.49B
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    Globus Medical Grew Earnings 56% On 6% Revenue. The Robotics Line Went Backwards.

    Q2 non-GAAP EPS $1.34, up 55.8% y/y; revenue $789.6M, +5.9%; company kept revenue guide $3.18-3.22B and raised adjusted EPS to $4.95-5.05 from $4.70-4.80 Enabling Technologies revenue fell 25.8% to $26.1M, now 3.3% of sales - robotics is a marginal, shrinking contributor...

    Glenn Ford
    •
    8/11/26
    •
    209
    Medical Devices, value investing
    Also mentions:
    MDTISRG

    Abbott: The Market Priced the Dent and Forgot the Cargo

    Market punished Abbott - stock down ~34% from 52-week high $139.06 to ~$91, yet TTM revenue $45.1B, gross margin 56.4%, operating cash flow $9.46B and free cash flow $7.38B ($4.22/sh, 4.85% FCF yield) Closed oncology acquisition for ~$21B equity (~$23B incl assumed debt), funded with $20B notes...

    Glenn Ford
    •
    6/9/26
    •
    271
    Dividend Kings, medical-technology, value investing
    Also mentions:
    MDTJNJ

    The Aristocrat Nobody Wanted: Why (MDT) Is Worth a Second Look Right Now

    (MDT) has raised its dividend for 48 consecutive years, yet trades at just 14x forward earnings. On a trailing basis it is 24x vs. (ISRG) at 57x and (SYK) at 40x. The 5-year dividend CAGR is 4.4%, slowing to 2.0% over three years. This is a yield anchor at 3.3%...

    Glenn Ford
    •
    4/8/26
    •
    165
    dividend aristocrats, value investing, Medical Devices
    Also mentions:
    ISRGABTSYK

    When the Old Playbook Fails: Building a Real Defensive Portfolio for the 2026 Oil Shock

    The S&P 500 is already 5% off its January peak. A 10% correction only needs another 5.3% lower and current models put that at 72% probability before year-end 2026. This correction is oil-driven...

    Glenn Ford
    •
    3/15/26
    •
    463
    market correction, defensive stocks
    Also mentions:
    NVSPEGMDTAEM

    Why TransMedics Stock is a Buy for Long-Term Investors

    TransMedics is replacing a 60-year-old organ-transport method with its FDA-approved OCS platform, which keeps hearts, lungs, and livers alive and functioning during transit — a massive step-change in reliability and outc Business model now prints cash...

    Glenn Ford
    •
    11/14/25
    •
    295
    medical-technology, healthcare-innovation, organ-transplant, growth-stocks
    Also mentions:
    ISRGSYKMDTABTEW

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    290
    New Awards (TTM)
    246
    Avg Remaining Term
    5.9 mo

    Recent Awards

    Award IDAgencyObligatedStart
    36A79726F0188Department of Veterans AffairsDepartment of Veterans Affairs$1.11MMay 26, 2026
    36A79726F0066Department of Veterans AffairsDepartment of Veterans Affairs$938676Dec 31, 2025
    36A79726F0087Department of Veterans AffairsDepartment of Veterans Affairs$823060Jan 16, 2026
    36A79726F0100Department of Veterans AffairsDepartment of Veterans Affairs$582746Jan 29, 2026
    36A79726F0175Department of Veterans AffairsDepartment of Veterans Affairs$533246Apr 15, 2026
    36A79726F0003Department of Veterans AffairsDepartment of Veterans Affairs$454798Oct 4, 2025
    36C25625P1369Department of Veterans AffairsDepartment of Veterans Affairs$427940Sep 15, 2025
    36C25726N0409Department of Veterans AffairsDepartment of Veterans Affairs$266400Jul 15, 2026
    36C25726F0070Department of Veterans AffairsDepartment of Veterans Affairs$256275Apr 24, 2026
    SPE2D126F0028Department of DefenseDefense Logistics Agency$218431Oct 28, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Medtronic Quietly Raised Its Dividend Again. Is It a Buy for Income Investors?

    Medtronic recently raised its quarterly dividend for the 49th consecutive year, albeit with a modest 1.4% increase...

    24/7 Wall St.•10/27/26•Neutral

    Insulin Patch Pump Market to Reach US$ 5.53 Billion by 2035, Driven by Rising Diabetes Cases and Demand for Wearable Insulin Delivery Devices

    The global insulin patch pump market is projected to reach US$ 5.53 billion by 2035, growing at a CAGR of 12.3% from US$ 1.72 billion in 2025. This growth is driven by the increasing prevalence of diabetes...

    openPR.com•10/27/26•Somewhat-Bullish

    Medtronic appoints Marinaro president. Medtronic stock sits 6.43 percent below its high

    Michael Marinaro was appointed president of Medtronic effective October 14, 2026, expanding his responsibilities to include Greater China. The company's fiscal first-quarter revenue increased by 13.70 percent to USD 9.76...

    ad-hoc-news.de•10/27/26•Bullish

    Global Hospital Command Center Software Market Expected to Reach $3.59 Billion by 2030

    The global Hospital Command Center Software market is projected to reach $3.59 billion by 2030, driven by the increasing demand for real-time hospital operations management, better patient flow...

    EIN News•10/26/26•Somewhat-Bullish

    Dale Brady Joins Nuwellis as Principal R&D Engineer

    Nuwellis Inc. has appointed Dale Brady as Principal R&D Engineer to advance its existing and new product development programs. Brady brings over 25 years of medical device leadership experience...

    Medical Product Outsourcing•10/26/26•Somewhat-Bullish

    MDT Valuation and Fair Value

    P/E
    16.6x
    Forward P/E
    14.3x
    EV/EBITDA
    14.4x
    P/FCF
    19.8x
    PEG
    1.7x
    P/B
    2.4x
    See GNG's fair value

    MDT Profitability: Margins, ROIC and FCF

    Gross margin
    65.0%
    Operating margin
    19.3%
    Net margin
    13.9%
    ROIC
    7.5%
    ROE
    10.6%
    FCF margin
    16.3%
    FCF yield
    5.1%

    MDT Competitors

    CompanyTicker
    Bristol-Myers Squibb CompanyBMY
    CVS Health CorpCVS
    Vertex Pharmaceuticals IncVRTX
    Stryker CorporationSYK
    Intuitive Surgical IncISRG
    McKesson CorporationMCK
    Danaher CorporationDHR
    GlaxoSmithKline PLC ADRGSK

    Sector: Healthcare

    MDT Analyst Ratings

    Consensus
    Buy
    Analysts
    28
    Strong Buy
    3
    Buy
    16
    Hold
    9
    Sell
    0
    Strong Sell
    0

    MDT Bull Case vs Bear Case

    Bull case

    • MDT converts 16.3% of revenue into free cash flow.
    • MDT beat EPS estimates in 100.0% of its last 8 reported quarters.
    • MDT grew quarterly revenue 13.7% year over year.

    MDT Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    2.3%
    EPS estimate (fiscal period ending Oct 31, 2026)
    $1.33
    Estimate revisions (30 days, fiscal period ending Oct 31, 2026)
    1 up, 1 down

    MDT Dividend

    Forward yield
    3.0%
    Payout ratio
    45.6%
    3Y DPS growth
    2.0%
    5Y DPS growth
    4.4%
    Pay months
    Jan, Apr, Jul, Oct
    MDT dividend history

    Frequently Asked Questions About MDT

    What is MDT's current dividend yield?

    Medtronic PLC (MDT) has a forward dividend yield of 3.04%.

    Does MDT pay dividends?

    Yes, Medtronic PLC pays dividends with a forward dividend yield of 3.04%.

    What is MDT's P/E ratio?

    Medtronic PLC has a price-to-earnings (P/E) ratio of 16.57.

    What is MDT's market cap?

    Medtronic PLC (MDT) has a market capitalization of $122.04B with a current stock price of $94.78.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In